How digital medication adherence monitoring increases the impact of innovative adherence research?

The pharmaceutical industry has spent years discussing patient centricity. But a new reflection paper from the European Medicines Agency (EMA) suggests something much more significant is happening: Patient experience data (PED) is evolving from supportive information into a structured component

A few eyebrows were raised in earlier this year when Bristol Myers Squibb (BMS) announced the details of a noteworthy new partnership with investment firm Bain Capital. The agreement will see the creation of an entirely new, fully independent and